CLVS

Clovis Oncology, Inc. Competitors

$56.93
*  
0.29
0.51%
Get CLVS Alerts
*Delayed - data as of Dec. 22, 2014  -  Find a broker to begin trading CLVS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

Clovis Oncology, Inc.
CompanyName
Symbol: Market
LastSale NetChange ▼ Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Radius Health, Inc.
RDUS: NASDAQ-GM
$ 37.45 5.42 ▲ 2,157,506 $ 42.57
$ 30.46
$ 32.82
$ 7.46
NE 1,233,003,800
Enanta Pharmaceuticals, Inc.
ENTA: NASDAQ-GS
$ 51.32 4.70 ▲ 1,352,745 $ 51.47
$ 47.5844
$ 49.09
$ 27
29.16 953,679,560
MacroGenics, Inc.
MGNX: NASDAQ-GS
$ 38.58 4.05 ▲ 730,587 $ 39.8999
$ 35.51
$ 41
$ 17.31
NE 1,072,331,100
Immune Design Corp.
IMDZ: NASDAQ-GM
$ 36.19 3.13 ▲ 230,971 $ 38.82
$ 33.06
$ 36.69
$ 11.51
NE 610,851,010
Versartis, Inc.
VSAR: NASDAQ-GS
$ 23 3.11 ▲ 216,915 $ 23.41
$ 19.84
$ 36.86
$ 16.1531
NE 556,485,000
Receptos, Inc.
RCPT: NASDAQ-GS
$ 136.43 2.82 ▲ 511,600 $ 137.99
$ 130.05
$ 135.37
$ 24.5345
NE 4,297,408,570
Zafgen, Inc.
ZFGN: NASDAQ-GS
$ 28.38 2.54 ▲ 195,904 $ 28.81
$ 25.84
$ 26
$ 16.01
NE 644,424,660
Cubist Pharmaceuticals, Inc.
CBST: NASDAQ-GS
$ 100.47 1.80 ▲ 6,495,694 $ 100.97
$ 100.15
$ 101.03
$ 58.50
124.04 7,665,358,650
Shire plc
SHPG: NASDAQ-GS
$ 218.51 1.78 ▲ 851,443 $ 219.71
$ 216.09
$ 264.98
$ 136.682
33.16 130,796,152,820
Alnylam Pharmaceuticals, Inc.
ALNY: NASDAQ-GS
$ 102.48 1.75 ▲ 535,040 $ 104.05
$ 98.49
$ 112.57
$ 47.03
NE 7,883,888,880
Advaxis, Inc.
ADXS: NASDAQ-CM
$ 7.31 1.70 ▲ 3,818,775 $ 7.88
$ 5.8551
$ 5.99
$ 2.46
NE 142,676,580
Ligand Pharmaceuticals Incorporated
LGND: NASDAQ-GM
$ 54.01 1.69 ▲ 184,907 $ 54.18
$ 51.85
$ 80.42
$ 41.99
168.78 1,081,442,230
ANI Pharmaceuticals, Inc.
ANIP: NASDAQ-GM
$ 55.82 1.66 ▲ 166,971 $ 56.27
$ 53.5315
$ 61.43
$ 16.72
52.17 631,826,580
Five Prime Therapeutics, Inc.
FPRX: NASDAQ-GS
$ 27.39 1.50 ▲ 363,015 $ 27.83
$ 25.59
$ 26.24
$ 10.50
NE 590,281,890
Pharmacyclics, Inc.
PCYC: NASDAQ-GS
$ 132.82 1.37 ▲ 710,786 $ 134.28
$ 129.55
$ 154.89
$ 82.51
121.85 10,033,089,980
Advaxis, Inc.
ADXSW: NASDAQ-CM
$ 3.2081 1.31 ▲ 356,595 $ 3.7773
$ 2
$ 2.63
$ .75
NE 14,567,982
Achillion Pharmaceuticals, Inc.
ACHN: NASDAQ-GS
$ 15.49 1.28 ▲ 45,519,477 $ 16.87
$ 14.56
$ 15.31
$ 2.45
NE 1,552,826,030
Agios Pharmaceuticals, Inc.
AGIO: NASDAQ-GS
$ 120.87 1.25 ▲ 682,504 $ 122.8499
$ 116.69
$ 124.3899
$ 21.38
NE 4,192,134,210
Johnson & Johnson
JNJ: NYSE
$ 106.74 1.19 ▲ 8,120,033 $ 106.83
$ 105.67
$ 109.49
$ 86.09
17.67 298,777,001,400
Tetraphase Pharmaceuticals, Inc.
TTPH: NASDAQ-GS
$ 38.57 1.09 ▲ 510,869 $ 38.73
$ 36.90
$ 39.50
$ 8.01
NE 1,182,479,060
Aratana Therapeutics, Inc.
PETX: NASDAQ-GM
$ 17.50 1.07 ▲ 1,050,135 $ 18.16
$ 15.81
$ 25.50
$ 9.20
NE 607,337,500
Auspex Pharmaceuticals, Inc.
ASPX: NASDAQ-GM
$ 54.36 0.99 ▲ 314,334 $ 54.50
$ 51.80
$ 54.30
$ 13.25
NE 1,499,357,520
ContraFect Corporation
CFRX: NASDAQ-CM
$ 3.75 0.95 ▲ 285,675 $ 4.44
$ 2.80
$ 5.50
$ 2.50
NE 75,813,750
Assembly Biosciences, Inc.
ASMB: NASDAQ-CM
$ 7.81 0.91 ▲ 97,942 $ 7.93
$ 6.56
$ 23.4505
$ 4.25
NE 83,153,070
Ultragenyx Pharmaceutical Inc.
RARE: NASDAQ-GS
$ 49.27 0.89 ▲ 243,726 $ 49.74
$ 47.56
$ 69.7738
$ 32.02
NE 1,571,663,730